TP53 and polycystic ovary syndrome: This association is reaffirmed by our present study, which demonstrates a concurrence between elevated androgen levels, heightened NR3C4 expression in a PCOS model, and upregulated expression of p53 and BAX along with downregulated expression of anti-apoptotic Bcl-2.